Active Pharmaceutical Ingredients (API)
- Apomorphine hydrochloride
- Ascorbic Acid
- Azithromycin Dihydrate
- Benfotiamine
- Caffeine
- Cannabidiol (CBD)
- Carbocisteine
- Cefotaxime
- Ceftazidime
- Ceftriaxone
- Clarithromycin
- Cyanocobalamin (Vit B12)
- Diclofenac Sodium
- Dimetindene Maleate
- Heparin Sodium
- Lidocaine
- Mupirocin Calcium and Base
- Octenidine Dihydrochloride
- Prilocaine
- Rifaximin
- Sodium Ascorbate
- Acyclovir
- Alprazolam
- Amlodipine
- Arthemether
- Atenolol
- Atorvastatin
- Atracurium besylate
- Bacitracin
- Candesartan
- Captopril
- Carbamazepine
- Cetirizine
- Ciprofloxacin
- Clopidogrel
- Desloratadine
- Diazepam
- Domperidone
- Enalapril
- Exemestane
- Fluoxetine
- Folic Acid
- Fusidate sodium
- Glibenclamide
- Ibuprofen
- Ivabradine
- Levetiracetam
- Lumefantrine
- Mefenamic Acid
- Meloxicam
- Midazolam
- Nimesulide
- Ondansetron
- Pantoprazole
- Paracetamol
- Piroxicam
- Polymyxin Sulfate B
- Promethazine
- Ropivacaine
- Sertraline
- Simvastatin
- Sucralfate
- Terbinafine
- Tiamine
- Ticlopidine
- Tramadol hydrochloride
- Zinc oxide
Note:
The mentioned products shall not be offered, sold or used in any country where such products are covered by patents, other than for research and development purposes, in compliance with applicable laws and regulations, including Article 10.6 of Directive 2001/83/EC and corresponding national provisions.